home All News open_in_new Full Article

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced equity inducement grants to four new non-officer employees consisting of an aggregate of 78,600 share options and 1,800 performance share units […]


today 13 h. ago attach_file Other

attach_file Economics
attach_file Other
attach_file Science
attach_file Politics
attach_file Transport
attach_file Events
attach_file Other
attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Politics
attach_file Society
attach_file Culture
attach_file Events
attach_file Politics
attach_file Events


ID: 2629654980
Add Watch Country

arrow_drop_down